Sign In
Buy CTMX
$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. (“CytomX” or the “Company”) (CTMX) and certain of its officers. The class action, filed in
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, CCL and WFC
09:15pm, Friday, 19'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 19, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. S
NEW YORK, NY / ACCESSWIRE / June 19, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ:CTMX) between May 17, 2018, and
New York, New York--(Newsfile Corp. - June 19, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
BidaskClub Upgrades CytomX Therapeutics (NASDAQ:CTMX) to “Buy”
01:28am, Friday, 19'th Jun 2020
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by equities research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Friday, BidAskClub reports. Sever
Is CytomX Therapeutics (CTMX) Stock Outpacing Its Medical Peers This Year?
03:30pm, Thursday, 18'th Jun 2020
Is (CTMX) Outperforming Other Medical Stocks This Year?
LOS ANGELES, CA / ACCESSWIRE / June 17, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("C
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Conn’s, Inc. (CONN), Elanco An
New York, New York--(Newsfile Corp. - June 17, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) ("CytomX" or the "C
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the C
NEW YORK, NY / ACCESSWIRE / June 17, 2020 / Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. ("CytomX" or the "Company") (NASDAQ:CTMX) ...
Hedge Funds Standing By CytomX Therapeutics, Inc. (CTMX)
09:50pm, Tuesday, 16'th Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
NEW YORK, June 16, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17,.
New York, New York--(Newsfile Corp. - June 16, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) ("CytomX" or the "C
Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. (“CytomX” or the “Company”) (CTMX) and certain of its officers. The class action, filed in
